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Abstract
Paraquat dichloride has been  used by farmers as a herbicide to kill the grass. On the other hand, paraquat 
dichloride is harmful if enters to the body, causing Parkinson’s disease, since it is disrupting dopamine 
production in the substantia nigra pars compacta or dopamine pathways Nigro striatal pathway. The study 
was done to fi nd out the histological changes of catecholaminergic neurons and Nigro striatal pathway caused 
by paraquat dichloride treatment in Wistar rats as a model of Parkinson’s disease.
Twenty-two Wistar rats 3,5 months old were divided into 4 groups, 5 rats each. Group I (control group) 
were injected with aquabidest, while groups II, III, and IV were injected intraperitoneally with paraquat 
dichloride in aquabidest, with the dosage 5 , 10  and 15 mg/kg bw respectively. The rats were injected once 
per week for 6 weeks. Three days after the last injection, the rats were anesthetized using xylasin (2 mg/kg) 
and ketamine (20 mg/kg) intramuscularly, and then were intracardiac perfused using physiological saline as 
prerinse solution, followed by 10% buffered formalin solution as a fi xative. After animals were fi xed, the brains 
were removed and embedded in paraffi n block and cut in 12 μm thickness for immunohistochemistry staining 
using tyrosine hydroxylase antibody. The results of staining then were observed under light microscope and 
analyzed descriptively.
The results showed that the catecholaminergic neurons were distributed in the substantia nigra 
pars compacta in all treatment groups, however, the cell density were found decreased only  in group IV. 
Catecholaminergic neurons appear in the bipolar and multipolar form, while dopamine ‘Nigro striatal pathway’ 
was found exist in all treatment groups.  From our study,  histologycally the decreased of  catecholaminergic 
neurons is only found  in rats that received paraquat dichloride in dose 15 mg/kg bw  for 6 weeks.  
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Introduction
P a r k i n s o n ’ s  d i s e a s e  i s  a 
neurodegenerative disease that affects 
many elderly people due to the destruction 
of dopaminergic neurons in the substantia 
nigra (Uversky, 2004) or disruption of the 
Nigro-striatal pathway that is the pathway of 
dopaminergic from the substantia nigra to 
the striatum (Betarbed et al, 2002). Previous 
studies have been conducted on the effects 
of paraquat dichloride in animal models is 
the toxic dose in rats ranged from 150-231 
mg/kg, with a primary cause of death due to 
pulmonary damage (Gupta, 2007), the blood 
chemistry showed increased of creatinin, 
albumin and total bilirubun (Schober, 2004; 
Cicchetti, 2005). Tanner et al. (2011) reported 
that a Parkinson disease was associated 
Indonesian Journal of Biotechnology, June, 2014 Vol. 19, No. 1, pp.91-98
I.J. Biotech.
92
Pangestiningsih et al.
with the expose of paraquat to the body that 
causes oxidative stress in mitochondria. 
This research used low doses of paraquat 
dichloride, but in a long periods treatment to 
describe how the farmers suffering Parkinson 
disease in the fi eld. The succeed of Parkinson 
disease therapy is very low until now, due to 
many factors. To answer why this situation 
is happen, the investigation on many aspects 
of the Parkinson disease mechanism is 
very urgent to do, so the prevention can be 
done from the beginning. Recently research 
showed that any environmental infl uences 
such as the use of chemicals in agriculture, 
heavy metal exposure, and genetic factors, 
such as autosomal recessive juvenile, potential 
causing Parkinson disease (Uversky, 2005).
In daily activities, farmers often use 
herbicides to kill weeds that interfere with the 
productivity of the crops. Paraquat dichloride 
(1,1 dimethyl-4, 4  bipyridinum) is a phytotoxic 
herbicide , usually used to kill or inhibit the 
growth of grass (Gupta, 2007). Worldwide use 
of herbicides occurred during era of agriculture 
modernization almost reached 48% of total 
pesticide used. Such increasing is corespond 
with the changing of monoculture farming 
pattern and agricultural mechanization due 
to the increasing of the wages of the farmers. 
However, the use of herbicides in long period 
is threatening the farmer it self, and one of 
the potential disease causes by herbicides is 
Parkinson’s disease (Betarbed et al, 2002).
P a r k i n s o n ’ s  d i s e a s e  i s  a 
neurodegenerative disease caused by the 
destruction of dopaminergic neurons in the 
substantia nigra pars compacta (Emborg, 
2004). Dopamine is a neurotransmitter 
of catecholamine group, and  synthesis 
of catecholamine is requires tyrosine 
hydroxylase enzyme (TH), hence the presence 
of these enzymes in the organs/tissues 
can be used as a marker of the presence 
of catecholaminergic cell (Reiner, 1994). 
Microscopic image of Parkinson’s disease is 
characterized by the formation of Lewy bodies 
which are eosinophilic in the dopaminergic 
neurons(Uversky, 2004; Schober, 2004).
The aim of the research is to determine 
the effect of some low dose of paraquat 
dichloride to the histological changes of 
catecholaminergic neurons in the substantia 
nigra of Wistar rat’s. Tyrosine hydroxylase 
antibody was used as the marker of 
catecholaminegic neurons in the substantia 
nigra using immunohistochemistry staining 
techniques. From this research we expect 
to fi nd the saver dose and period in using 
paraquat dichloride as herbicide to avoid 
Parkinson’s disease. According to Andreollo 
et al. (2012),  every one day of  rat is equal 
to 30 days of the man’s life.  Six weeks of 
paraquat dichloride treatment to the rat in 
this study is approximately equal to 3,5 years 
of human life.
Materials And Methods 
Materials
Twenty female Wistar rats (Rattus 
norvegicus Albinus),  3.5 months old were use 
as the animal model. Materials used to induce 
Parkinson’s disease is paraquat dichloride 
(1,1 ‘dimethyl-4, 4’bipyridinium) diluted in 
aquabidest. The animals were euthanazed 
using Ketamine and xylasin, while perfusion 
were done using  physiological saline and 
buffered formaldehyde. Materials used for 
histology and staining process were ethanol, 
xylol, paraffi n, phosphate buffered Saline (PBS), 
blocking endogenous peroxidase, the primary 
antibody anti-TH mouse serum (Immunostar, 
Cat. No. 22941), and kit Startrek Universal 
HRP Detection (Biocare Medical, USA, 
Cat. No.STUHRP700 L10) that consist of 
blocking background material, secondary 
antibody, avidin-biotin, and chromogen 
3,3-diaminobenzidine tetrahydrochloride (DAB). 
The equipment used were the infusion set, 
microtechnic set, light microscope with a 
digital camera.   
Methods 
Perfusion and preparation of the brain 
samples
Rats were divided into 4 groups, each 
group consisted of 5 animals. Group I was 
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the control group injected with aquabidest, 
group II were injected with 5 mg/kg paraquat 
dichloride, group III (10 mg/kg), and 
group IV (15 mg/kg). Rats were injected 
intraperitonial once per week for 6 weeks. 
Three days after the last injection, the 
rats were anaesthetized using combination 
xylasin (2 mg/kg) and ketamine (20 mg/
kg)  by intramuscularly injection. During 
anasthesized condition, the rats were perfused 
intracardially using physiological saline as a 
pre-rinse. Intracardiac perfusion were done by 
fl owing pre-rinse solution to the left ventricle 
and let it out from right atrium.   The fi xative 
solution (10% buffered formalin) was fl owed 
into the left ventricle following the pre-rinse 
after the pre-rinse solution that fl ow out from 
the right atrium was free from blood. The 
fi xative solution was perfused until the whole 
body well fi xed. Once the perfusion process 
completed, the brains were collected and 
fi xed with 10% buffered formalin solution. 
The brain was cut longitudinally in the 
mid line into two parts. The left side was cut 
in the coronal of mesensephalika fl exure area 
with 5 mm thick, then were blocked using 
paraffi n. The hemispheres then were stored 
for histological examination.
The process of paraffi n blocking and tissue 
sectioning 
Slices of brain were inserted into the 
tissue cassette, followed by dehydration 
process that carried out in serial solution 
of ethanol 70%, 80%, 95%, and absolute 
ethanol for 60 min each at room temperature. 
Purifi cation (clearing) process was conducted 
by mixing xylol and 100% ethanol solution, 
followed by xylol twice,  for 45 minutes each 
at room temperature. Paraffi n infi ltration was 
conducted three times, for 45 minutes each, at 
60ºC, then were embedded in paraffi n , then 
cooled at room temperature. 
Paraffin block were cutted in 12 μm 
thick using a rotary microtome, then placed 
on the surface of warm water (45ºC) and 
placed on object glass that have been coated 
by gelatin and vertically drained. Glass 
object then placed on a slide warmer until 
well adhered.
Immunohistochemical staining of tyrosine 
hydroxylase 
Slides of the tissue  were arranged in 
racks and incubated at 60ºC for 2 hours, then 
were cooled at room temperature . Tissue was 
deparaffi ned in xylol, three times 5 minutes 
each and continued by rehydration process 
in absolute alcohol, twice in 90% alcohol, 
followed once in alcohol 80%, alcohol 70%, 
5 minutes each. After that, the slides were 
dipped in distilled water for 10 dips, then 
washed three times in phosphate buffered saline 
(PBS), each for 5 minutes. 
Endogenous peroxidase in the tissue 
was blocked by immersing slides in to 3% 
H2O2 for 30 minutes, then were rinsed three 
times in PBS, 10 minutes each. Surfaces 
around the slides were dried using tissue 
paper and keep the tissues moist. Slides 
then were aligned horizontally in a humid 
box, then tissue were spilled with Revealit 
Antigen solution and incubated at 37°C one 
night. Slides  then were rinsed four times 
in PBS solution, 10 minutes each.  Blocking 
background were done using  a sniper for 15 
min at room temperature.
Primary antibody Rat anti- tyrosine 
hydroxylase mouse serum (1/2500) were 
applied to the adrenal tissue of the treatment 
groups, while the adrenal tissue of the control 
groups containing tyrosine hydroxylase  were 
not treated with primary antibody. Slides 
then were placed horizontally in a humid 
box and incubate  for 2 nights at 4°C, then 
rinsed four times with PBS, for 15 minutes 
each. Furthermore, tissue was incubated at 
room temperature with a secondary antibody 
(Trekkie Universal Link) for 20 minutes, then 
rinsed three times using PBS, for 5 minutes 
each. Tissues were spilled with  TrekAvidin-
HRP for 10 minutes and then were rinsed 
three times with PBS, 5 minutes each, then 
incubated with Betazoid DAB + substrate 
solution for 3 minutes. Tissues then were 
washed in distilled water for 10 dips and 
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stained with hematoxylin for 1 minute as 
a counterstained. Finally, the  tissues were 
dehydrated in alcohol, cleared in xylol, and 
coversliped using  Canada balsam.
Staining results
The results of immunohistochemical 
staining of tyrosine hydroxylase based on 
the presence of catecholaminergic neurons 
Nigro-striatal pathway then were observed 
under microscope, and photographed by 
digital camera. Immunoreactived neurons 
were characterized by brownished yellow 
color of the cell. Three slides from each brain 
were observed for histology examination.
Analysis of research results
The images were processed with 
Adobe Photoshop 7.0 software and analyzed 
descriptively. 
Results and Discussion
Catecholaminergic neurons in the substantia 
nigra 
Based on the observation, we found 
that  catecholaminergic  neurons are 
distributed in the substantia nigra pars 
compactacompacta (SNc) both of the treated 
rats group and the control group. Position 
of  SNc is  in the dorsal of substantia nigra 
pars reticulata (SNr). Catecholaminergic 
neurons are immunoreactived neurons 
Figure 1. Catecholaminergic neurons in the substantia nigra pars compacta of rats after injected intraperitoneally 
with aquades, once a week for 6 weeks by tyrosine hydroxylase immunohistochemical staining. A. control’s; B. dose 
5 mg/kg bw’s; C. dose 10 mg/kg bw’s; D. dose 15 mg/kg bw’s groups. Tyrosine hydroxylase immunoreactived 
neurons are catecholaminergic neurons, showed brown in color. SNc: substantia nigra pars compacta. SNr: substantia 
nigra pars reticulata. 
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to tyrosine hydroxylase (TH) antibodies 
(TH) by  immunohistochemical staining 
(Figure 1). Catecholaminergic neurons 
substantia nigra pars compacta are bipolar 
and multipolar in shape (Figure 2).  The shape 
of  Catecholaminergic neurons substantia 
nigra pars compacta in  this research  is 
similar with the shape of catecholaminergic 
neurons substantia nigra pars compacta of 
rhesus monkey that was reported by Felten 
and Sladek (1983).
Catecholaminergic neurons in rats 
of treament group that injected paraquat 
dichloride in dose 15 mg/kg bw were showed 
decrease  in the cell densities compare with 
other groups, as shown in Figure 2D. The 
decrease  in the cell densities are  possibility 
the process of the cell death, as described 
by Bertabet (2002) is paraquat dichloride 
penetrate the blood-brain barrier, then 
metabolized into MPP + metabolites that toxic 
to mitochondria of dopaminergic neurons 
in the substantia nigra pars compacta and 
causing disruption of respiration cells and 
cellular oxidative stressed.  According to 
Miller (2007) Paraquat can inhibit complex I 
of cell respiration process in mitochondria.
From the case-control study by Tanner et 
al. (2011) showed that Parkinson diseases are 
associated with paraquat. Their suggestion 
Figure 2. Type of catecholaminergic neurons in the substantia nigra pars compacta of rats after injected intraperitoneally 
with aquades, once a week for 6 weeks by tyrosine hydroxylase immunohistochemical staining. A. control’s; B. dose 
5 mg/kg bw’s; C. dose 10 mg/kg bw’s; D. dose 15 mg/kg bw’s groups. Tyrosine hydroxylase immunoreactived 
neurons are catecholaminergic neurons, showed brown in color. Catecholaminergic neurons are  bipolar (*) and 
multipolar (**) in shape. Figure D showed the decreased of neuronal denstity of catecholaminergic neurons compared 
with Figure A, B and C.
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is paraquat increases production of certain 
oxygen derivate that may harm cell structure. 
In this research  it is likely, some cells unable 
to overcome with oxidative stress that 
caused cell death. Further research needs to 
investigate the occurrence of oxidative stress 
by using its specifi c marker. 
Based on the clinical symptoms, treated 
rats did not showed the typical signs of 
Parkinson’s disease such as tremor, rigidity, 
and diffi culty moving. It is likely, the cell 
damaged that occured is still able to be 
overcome by the body.
The existence of Nigro-striatal pathway
The dopamine pathway is  expand from 
the substantia nigra pars compacta heading 
into the striatum, called Nigro-striatal pathway 
as found on the treated groups. This pathway 
begins with catecholaminergic neuron 
cell bodies that produce dopamine in the 
substantia nigra pars compacta, then carried 
by the axon toward the axon terminals in 
the striatum, as shown in Figure 3. Rats that 
received paraquat dichloride in dose 15 mg/
kg bw showed the axon and axon terminal 
that immunoreactive to tyrosine hydroxylase 
antiboby (Figure 4) which is indicated that 
Nigro-striatal pathway exist in this group. The 
existence of Nigro-striatal pathway showed 
that the dopamine system has been working 
properly so that the animals did not suffered 
of rigidity although the group of rats that 
received paraquat dichloride in dose 15 mg/
kg showed weaker body condition compare 
with other groups.
Parkinson’s disease characterized by 
distruption of dopamine production in 
substantia nigra pars compacta or alteration 
of  Nigro-striatal pathway and showed  the 
clinical sign such as  as tremor, bradykinesia, 
hypokinesia, balance and movement 
disorders (Paxinos, 2004; Betarbed et al, 2002; 
Emborg, 2004).
The results of this study showed 
that although the rats did not showed 
symptoms of Parkinson’s disease and 
Nigro-striatal pathway is remain exist, but 
there is a decreased of neuronal density of 
catecholaminergic neurons in the substantia 
nigra pars compacta in the rats that reveived 
paraquat dichloride in dose 15 mg/kg bw. 
Based on this results, it is hypothetized that 
dose 15 mg/kg bw of paraquat dichloride 
treatment period caused neuronal changes of 
catecholaminergic neurons in the substantia 
nigra pars compacta and its potentially 
leading to Parkinson’s disease. 
Conclusions
From our study,  histologycally 
the  decreased neuronal  dens i ty  o f 
catecholaminergic neurons in substantia 
nigra pars compacta is only found in rats that 
Figure 3. Nigro-striatal pathway expand  from  the substantia nigra pars compacta (SNc) to the striatum (Str) in the rats 
who injected with 5 mg/kg BW paraquat dichloride intraperitoneally, once a week for 6 weeks, arrows indicating 
Catecholamines is carried by axons (*) to the axon terminal (**).  
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received paraquat dichloride in dose 15 mg/
kg bw  for 6 weeks.  
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